37M-10292-93451
4 vaccinations
2 coded responses
45 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 786 / TX
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
USA-25971-08158
Child or adolescent in my care · Male · 2021-11-16
Timeline
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 1 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-09
- 2021-02-17
- 2021-02-24
-
2021-02-25
Dose 2 — Pfizer-BioNTech
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-02-27
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Musculoskeletal chest pain — Feeling: Fair · Site: Pain · HeadacheFree text: Rib painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
- 2021-03-02
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-27
- 2021-04-01
- 2021-04-08
- 2021-05-27
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-05
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Back pain, Pain in extremity — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Lower back pain, legs pain severeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Abdominal painAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-13
- 2021-10-19
- 2021-10-28
- 2021-11-02
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2022-04-05
-
2022-09-17
Dose 4 — Pfizer-BioNTech
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-26
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-23
- 2022-10-29
- 2022-12-19
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-06 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Rib pain
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lower back pain, legs pain severe
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Back pain | · | · | ✓ |
| SRO | Musculoskeletal chest pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release